Merck Global Health Innovation Fund

Merck Global Health Innovation Fund, known as GHI, is the corporate venture arm of Merck for healthcare technology. It invests worldwide in platform companies whose technology or business model is already proven and where Merck's know-how can speed up growth. The fund has made over sixty digital health investments.

Products and services

• Therapy planning: diagnostic tools, patient profiling and clinical decision support.
• Care management: care coordination, patient education and engagement, and population health monitoring.
• Health analytics and AI: turning large data sets into real-world evidence.
• eClinical trials: better site selection, patient recruitment and protocol adherence through analytics and mobile tools.
• Enabling technologies: tools for clinical operations, regulatory work, pharmacovigilance and supply chain.

Customers and markets

Digital health companies, with a therapeutic emphasis on oncology, central nervous system disorders, immunology and virology. It also connects portfolio firms with complementary technologies to build joined-up healthcare products.

Key facts

• Backed by: Merck
• Investments: more than sixty in digital health